Showing results (471-480 of 546) with videos related to

Sort By:
Pageof 55
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 25, 2012
Intensity-modulated arc therapy with cisplatin as neo-adjuvant treatment for primary irresectable cervical cancer. Toxicity, tumour response and outcomeK Vandecasteele, A Makar, R Van den Broecke, et al.
Antimicrobial Agents and Chemotherapy|June 17, 2009
Simple, rapid, and inexpensive detection of Neisseria gonorrhoeae resistance mechanisms using heat-denatured isolates and SYBR green-based real-time PCRGayle Kugelman, John W Tapsall, Namraj Goire, et al.
BMC Infectious Diseases|December 13, 2012
Household transmission of respiratory viruses - assessment of viral, individual and household characteristics in a population study of healthy Australian adultsJames M McCaw, Peter F Howard, Peter C Richmond, et al.
Mutation Research|December 6, 2001
Cellular determinants of the mutational specificity of 1-nitroso-6-nitropyrene and 1-nitroso-8-nitropyrene in the lacI gene of Escherichia coliI B Lambert, C Carroll, N Laycock, et al.
Journal of Infection and Public Health|January 29, 2025
Assessing the impact of non-pharmaceutical interventions against COVID-19 on 64 notifiable infectious diseases in Australia: A Bayesian Structural Time Series modelShovanur Haque, Stephen B Lambert, Kerrie Mengersen, et al.
Communicable Diseases Intelligence Quarterly Report|December 2, 2015
Medically-attended respiratory illnesses amongst pregnant women in Brisbane, AustraliaPrecious Rufus Ashiedu, Ross M Andrews, Stephen B Lambert, et al.
Sexually Transmitted Infections|August 20, 2010
Evaluation of the cobas 4800 CT/NG test for detecting Chlamydia trachomatis and Neisseria gonorrhoeaeRebecca Rockett, Namraj Goire, Athena Limnios, et al.
Pediatric Pulmonology|January 5, 2019
Nasal swab bacteriology by PCR during the first 24-months of life: A prospective birth cohort studyArto A Palmu, Robert S Ware, Stephen B Lambert, et al.
Clinical and Diagnostic Virology|May 1, 1996
Artificial mosaic proteins as new immunodiagnostic reagents: the hepatitis E virus experienceH A Fields, Y E Khudyakov, M O Favorov, et al.
Infectious Disease Modelling|June 6, 2025
Real-time inference of the end of an outbreak: Temporally aggregated disease incidence data and under-reportingI Ogi-Gittins, J Polonsky, M Keita, et al.
Pageof 55